Yonglong Xiao
Overview
Explore the profile of Yonglong Xiao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu M, Xu X, Xin X, Yang S, Wang Y, Xiao Y, et al.
Eur J Med Res
. 2025 Mar;
30(1):171.
PMID: 40087668
Objectives: Transbronchial lung cryobiopsy (TBLC) has been identified to be a new technique to diagnosis interstitial lung disease (ILD). The study was conducted to investigate the safety and the diagnostic...
2.
Liu Y, Jiang H, Zhao T, Cao M, He J, Qi R, et al.
BMC Pulm Med
. 2024 Dec;
24(1):602.
PMID: 39633326
Background: The prevalence of invasive pulmonary aspergillosis (IPA) among patients with interstitial lung disease (ILD) is steadily increasing, leading to high mortality. The purpose of this study is to analyze...
3.
Zhang M, Li W, Zhao Y, Qi L, Xiao Y, Liu D, et al.
PLoS One
. 2024 Aug;
19(8):e0307651.
PMID: 39186800
Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and stands as the second principal contributor to cancer-related fatalities. Recently, emerging research has emphasized the role of pan...
4.
Gui X, Li W, Jiang H, Wang R, Yu M, Zhao T, et al.
RMD Open
. 2024 Apr;
10(2).
PMID: 38663883
Objectives: Risk prediction for patients with polymyositis/dermatomyositis-associated interstitial lung disease (PM/DM-ILD) is challenging due to heterogeneity in the disease course. We aimed to develop a mortality risk prediction model for...
5.
Huang X, Si W, Ye X, Zhao Y, Gu H, Zhang M, et al.
BMJ Open Respir Res
. 2024 Mar;
11(1).
PMID: 38460976
Purpose: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is the primary cause of death in patients with IPF, characterised by diffuse, bilateral ground-glass opacification on high-resolution CT (HRCT). This study...
6.
Wang R, Shi S, Chen L, Zhang Y, Qiu X, Meng F, et al.
J Hematop
. 2024 Feb;
15(1):25-28.
PMID: 38358602
Familial hemophagocytic lymphohistiocytosis (FHL) is a genetically heterogeneous disorder which is less typical in adults than pediatric patients. In this study, we reported a rare case of adult-onset FHL3 with...
7.
Wang B, Jiang B, Du L, Chen W, Zhang Q, Chen W, et al.
Oncoimmunology
. 2024 Jan;
12(1):2279800.
PMID: 38264343
Background: Non-responsiveness is a major barrier in current cancer immune checkpoint blockade therapies, and the mechanism has not been elucidated yet. Therefore, it is necessary to discover the mechanism and...
8.
Liang Y, Fan S, Jiang Y, Ji T, Chen R, Xu Q, et al.
Int Immunopharmacol
. 2023 Aug;
123:110754.
PMID: 37573686
Circulating mitochondrial DNA (mtDNA) was implicated in idiopathic pulmonary fibrosis (IPF), but the association between circulating mtDNA levels with clinical parameters in IPF was unclear. In this study, we investigate...
9.
Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies
Huang X, Cao M, Xiao Y
Front Immunol
. 2023 Jun;
14:1195988.
PMID: 37388737
Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disorder that is characterized by the abnormal accumulation of surfactant within the alveoli. Alveolar macrophages (AMs) have been identified as playing a...
10.
Lyu W, Zhou W, Xu Q, Liu X, Liu Y, Zhang Y, et al.
Clin Exp Rheumatol
. 2023 Feb;
41(2):267-274.
PMID: 36826792
Objectives: Whether coagulopathy exists in development of idiopathic inflammatory myopathies associated rapidly progressive interstitial lung disease (IIMs-RPILD) is unclear. In this study, we aimed to investigate soluble CD40 ligand and...